• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Relistor (methylnaltrexone bromide) Subcutaneous injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – November 2009

 

Summary View

 

ADVERSE REACTIONS

  • hyperhidrosis

PATIENT INFORMATION

What are the possible side effects of Relistor?
  • Sweating